Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SEPN1 Rabbit anti-Human, Mouse, Polyclonal, Proteintech

Rabbit Polyclonal Antibody
Supplier: Proteintech Group Inc 553331AP150UL

Description
SEPN1 is a selenoprotein, which contains a selenocysteine (Sec) residue at its active site. Mutations in SEPN1 gene cause the classical phenotype of multiminicore disease and congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. This gene encodes a selenoprotein, which contains a selenocysteine (Sec) residue at its active site. The selenocysteine is encoded by the UGA codon that normally signals translation termination. The 3′ UTR of selenoprotein genes have a common stem-loop structure, the sec insertion sequence (SECIS), that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Mutations in this gene cause the classical phenotype of multiminicore disease and congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.Specifications
SEPN1 | |
Polyclonal | |
Unconjugated | |
SELENON | |
MDRS1, RSMD1, RSS, Selenoprotein N, selenoprotein N, 1, SELN, SEPN1 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
57190, 74777 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.39 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3 | |
D3Z2R5, Q9NZV5 | |
SELENON | |
Peptide | |
150 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction